Tissue factor pathway inhibitor levels in patients with homocystinuria.


Thrombotic events are a well-recognized complication of homocystinuria. However, the mechanisms involved in the atherogenic and thrombotic effects of homocyst(e)ine remain incompletely understood. The objective of this study was to determine the role of endothelial cell activation/damage as indicated by levels of thrombomodulin, tissue factor and tissue… (More)


Cite this paper

@article{Cella2000TissueFP, title={Tissue factor pathway inhibitor levels in patients with homocystinuria.}, author={G. Cella and Alberto B. Burlina and Alessandra Sbarai and G. Motta and Alessandro Girolami and Marco Berrettini and Warren J. Strauss}, journal={Thrombosis research}, year={2000}, volume={98 5}, pages={375-81} }